Repka M X, Wentworth D
Wilmer Ophthalmological Institute, Johns Hopkins University School of Medicine, Baltimore, Md.
J Pediatr Ophthalmol Strabismus. 1991 Jul-Aug;28(4):202-5. doi: 10.3928/0191-3913-19910701-04.
Results of the Prism Adaptation Study (PAS) indicate that prism adaptation improves the success rate of strabismus surgery for patients with acquired esotropia. Patients who show a fusion response to the prisms benefit most from this preoperative treatment. This study analyzes the characteristics of those patients who were and were not prism responders in the PAS. Significant factors predicting a prism response included: patients who were older at the time of onset of their esodeviation (P = .007), duration of deviation less than 1 year (P = .04), alternating fixation (P = .003), fusion on the Worth four-dot test at near with prism neutralization (P = .008), and equal vision (P = .009). Demographic characteristics were similar for both responders and nonresponders except that non-Hispanic patients were significantly more likely to respond to prisms than Hispanic patients (P less than .002). No test or characteristic was found which could reliably predict the prism response. Therefore, all patients with acquired esodeviations should be considered candidates for prism adaptation prior to strabismus surgery.
棱镜适应研究(PAS)的结果表明,棱镜适应可提高后天性内斜视患者斜视手术的成功率。对棱镜有融合反应的患者从这种术前治疗中获益最大。本研究分析了PAS中对棱镜有反应和无反应的患者的特征。预测棱镜反应的显著因素包括:内斜视发病时年龄较大的患者(P = .007)、斜视持续时间小于1年(P = .04)、交替注视(P = .003)、在近距使用棱镜中和时沃思四点试验中有融合(P = .008)以及视力相等(P = .009)。反应者和无反应者的人口统计学特征相似,只是非西班牙裔患者对棱镜有反应的可能性明显高于西班牙裔患者(P小于.002)。未发现能够可靠预测棱镜反应的测试或特征。因此,所有后天性内斜视患者在斜视手术前均应被视为棱镜适应的候选者。